Allergan PLC | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
392.44 M |
Public Float |
- |
Allergan PLC | |
Stock Exchange | Mexican Stock Exchange |
EPS |
MXN422.69 |
Market Cap |
MXN1.03 T |
Shares Outstanding |
392.44 M |
Public Float |
- |
Allergan PLC | |
Stock Exchange | New York Stock Exchange |
EPS |
$21.58 |
Market Cap |
$54.97 B |
Shares Outstanding |
327.82 M |
Public Float |
331.68 M |
Address |
Clonshaugh Business & Tech. Park Dublin Dublin D17 E400 Ireland |
Employees | - |
Website | http://www.allergan.com |
Updated | 07/08/2019 |
Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. |